Table 3. 5-aza sensitizes cells to TGF-β1 as indicated by IL11 expression.
Cell treatment | IL11 (n=10) | PRG4 (n=7) | NOX4 (n=13) | |||
---|---|---|---|---|---|---|
Median (min, max) | P value | Median (min, max) | P value | Median (min, max) | P value | |
SF | 1.69 (0.86, 2.22) | 0.070 | 1.44 (0.63, 3.22) | 0.084 | 1.11 (0.13, 3.62) | 0.352 |
TGF-β1 | 2.37 (1.68, 3.61) | 0.045 | 2.03 (1.01, 15.29) | 0.128 | 1.03 (0.52, 2.96) | 0.243 |
Human gingival fibroblasts were exposed to 5-aza or left untreated for 72 hours, before cells were stimulated with recombinant human TGF-β1 or left in SF medium alone. After 24 hours, the gene expression analysis was performed. P values reflect the ratio of gene expression in response to 5-aza compared to unstimulated cells. Statistical analyses were based on log-transformed values with the paired t-test.
5-aza: 5-aza-2'-deoxycytidine, TGF-β1: transforming growth factor-β1, IL11: interleukin-11, PRG4: proteoglycan 4, NOX4: NADPH oxidase 4, min: minimum, max: maximum, SF: serum-free.